WIPO trademark

VERICI DX

RegisteredWIPOClass 5Class 10Class 42Class 44

"VERICI DX" is a trademark owned by Renalytix AI, Inc., filed at the WIPO on January 6, 2021. It is registered and covers classes 5, 10, 42 and 44.

VERICI DX
Trademark as filed with the WIPO
Status
Registered
Filed
January 6, 2021
Registered
Not yet
Expires
January 6, 2031
Application no.
Not recorded
Registration no.
1576647
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
4 classes
Ownership

Who owns VERICI DX

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services VERICI DX is filed for, grouped by Nice class.

  • Medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and chemical reagents for medical purposes.

  • Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients.

  • Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis.

  • Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patients.

FAQ

About VERICI DX

Who owns the trademark "VERICI DX"?

The WIPO trademark "VERICI DX" is owned by Renalytix AI, Inc.

What is the status of "VERICI DX"?

Its status at the WIPO is: registered.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull VERICI DX and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_f1f4a1d5-41a4-4ebc-988e-67f4e86b29fa
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_f1f4a1d5-41a4-4ebc-988e-67f4e86b29fa",
  "object": "trademark",
  "mark_text": "VERICI DX",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2021-01-06",
  "nice_classes": [
    5,
    10,
    42,
    44
  ],
  "owners": [
    {
      "name": "RENALYTIX AI, INC.",
      "entity_id": "ent_019ebbcd-e128-75cd-9acb-4e4bedf5d366"
    }
  ]
}